| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/24/2005 | US6897207 Kinase inhibitors; angiogenesis inhibitors, anticancer agents, antiinflammatory agents and chronic obstructive pulmonary disease inhibitors |
| 05/24/2005 | US6897206 Combinations for the treatment of inflammatory disorders |
| 05/24/2005 | US6897203 Polysaccharidic esters of retinoic acid |
| 05/24/2005 | US6897044 Drugs for treatment of cancer/autoimmune disorders; apoptosis promoters |
| 05/24/2005 | US6896906 A spray dried powder prepared by aerosolization; superior chemical and physical stability over their solution counterparts; inhaleable powder |
| 05/24/2005 | US6896901 Controlling or preventing cognitive dysfunction, hyperglycemia and some infective conditions of the skin in mammals by administering pharmaceutically acceptable effective amount of gugulipid |
| 05/24/2005 | CA2307655C Tolerogenic fragments of natural allergens |
| 05/24/2005 | CA2109259C Prodrugs, their preparation and use as pharmaceuticals |
| 05/24/2005 | CA2037607C Humanised antibodies |
| 05/19/2005 | WO2005044283A1 Allergic constitution ameliorator |
| 05/19/2005 | WO2005044268A1 Preparation of pharmaceutical salts of [1, 4] - bipiperidine |
| 05/19/2005 | WO2005014576A8 Isoquinolinone derivative, process for producing the same and use thereof |
| 05/19/2005 | WO2005011732A3 Rabbit bacterium and uses thereof |
| 05/19/2005 | WO2004093894A8 Use of b7-h3 as an immunoregulatory agent |
| 05/19/2005 | WO2003014703A3 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
| 05/19/2005 | WO2003012035A3 Commercial use of arabidopsis for production of human and animal therapeutic and diagnostic proteins |
| 05/19/2005 | US20050107611 For use as adenosine receptor ligands; immunostimulants; contraceptives |
| 05/19/2005 | US20050107589 Membrane fusion protein for use as toole in the treatment and prevention of inflammatory bowel and autoimmune diseases |
| 05/19/2005 | US20050107585 Signal-1/signal-2 bifunctional peptide inhibitors |
| 05/19/2005 | US20050107457 Indazole derivatives as JNK inhibitors and compositions and methods related thereto |
| 05/19/2005 | US20050107434 heterocyclic amines such as 1-Cyclopentyl-4-{2-[5-(4-methanesulfonylphenyl)[1,2,4]oxadiazol-3-yl]ethyl}piperidine and salts, used as histamine-H3 receptor antagonists for treatment of nervous system, cardiovascular , respiratory system, gastrointestinal system and endocrinological system disorders |
| 05/19/2005 | US20050107429 Aqueous liquid preparations and light-stabilized aqueous liquid preparations |
| 05/19/2005 | US20050107428 Antiinflammatory agents; autoimmune diseases; rheumatic diseases; anticholesterol agents; cardiovascular disorders |
| 05/19/2005 | US20050107421 Nitrogen compounds such as 2-Butyl-1-(2-methylpropyl)-1H-tetrazolo[1,5-a]imidazo[4,5-c][1,8]naphthyridine, used to induce biosynthesis of cytokines such as interferons and tumor necrosis factors, or for prophylaxis of viral diseases |
| 05/19/2005 | US20050107418 Macrolides |
| 05/19/2005 | US20050107413 pyrimidine derivatives such as 4-Chloro-5,6-diphenyl-2-(trifluoromethyl)pyrimidine, used for the treatment of inflammation and immunological diseases |
| 05/19/2005 | US20050107388 Heteroaromatic urea derivatives as vr-1receptor modulators for treating pain |
| 05/19/2005 | US20050107384 to inhibit proliferative conditions, such as cancer and psoriasis; detecting or identifying a HDAC in a biological sample comprising detecting or measuring the formation of a complex between a labelled compound as defined in claim (I) and a HDAC |
| 05/19/2005 | US20050107354 Preventive or therapeutic agent for kidney disease |
| 05/19/2005 | US20050107347 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders |
| 05/19/2005 | US20050107345 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 05/19/2005 | US20050107340 Protein kinase modulators; cancer, diabetes, hepatic cirrhosis, cardiovascular disease such as atherosclerosis, angiogenesis, immunological disease such as autoimmune disease (e.g., AIDS and lupus) and renal disease |
| 05/19/2005 | US20050107330 Drug mixture contains a sympathomimetic selected from the group consisting oxymetazoline, xylometazoline, tramazoline, tetryzoline and naphazoline, and glycosaminoglycan of hyaluronic acid; synergistic effect; vasoconstrictor action, detumescent action on the nose mucous membrane |
| 05/19/2005 | US20050107293 Protein modification and maintenance polypeptides (PMOD) for use as diagnostic and therapeutic tools in treatment of prevention of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, developmental, epithelial, neurological, and reproductive disorders |
| 05/19/2005 | US20050106695 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 05/19/2005 | US20050106679 Leptin proteins |
| 05/19/2005 | US20050106678 Human circulating cytokine CC-1 |
| 05/19/2005 | US20050106677 Useful as a candidate for a vaccine against ticks, particularly Ornithodoros moubata |
| 05/19/2005 | US20050106672 Neurotransmission associated proteins |
| 05/19/2005 | US20050106658 Remodeling and glycoconjugation of peptides |
| 05/19/2005 | US20050106581 Phosphodiesterase polypeptides for use in identifying modulators for prevention and treatment of inflammatory disease |
| 05/19/2005 | US20050106558 Generating viral expression vector comprising parvoviral structural genes for use as gene transfer and expression tool; treatment and prevention of infections, cell proliferative and autoimmune disorders |
| 05/19/2005 | US20050106211 Fabrication of drug loaded biodegradable polymer fibers |
| 05/19/2005 | US20050106189 Pharmaceutical formulation comprising cyclosporin and use thereof |
| 05/19/2005 | US20050106176 Vector reproduction using Dna polymerase; linking to chromosome; encoded as foreign gene; genetic engineering |
| 05/19/2005 | US20050106153 mixture of immunoadjuvant in neoplasm; applying stresses to destroy neoplastic tissue; administering immunomoderator ; in situ generation of autologous vaccine |
| 05/19/2005 | US20050106143 Collapsin response mediator protein; measurement of gene expression |
| 05/19/2005 | US20050106142 Rheumatic arthritis; hepatitis c virus; autoimmune diseases ; nterfering with forming or binding of such; autoantigen |
| 05/19/2005 | US20050106140 Antagonistic anti-hfas ligand human antibodies and fragments thereof |
| 05/19/2005 | US20050106136 Controlling capilalries, blood vessels in eye; vision defects |
| 05/19/2005 | US20050106133 Containing lactobacillus; storage stability |
| 05/19/2005 | US20050106129 Method of obtaining immune cells from an animal |
| 05/19/2005 | DE10148828B4 Modulation der Expression STAT-1-abhängiger Gene Modulating the expression of STAT-1-dependent genes |
| 05/19/2005 | CA2544853A1 Use of antagonist anti-cd40 antibodies for treatment of autoimmune and inflammatory diseases, and organ transplant rejection |
| 05/19/2005 | CA2544845A1 Preparation of pharmaceutical salts of [1, 4] - bipiperidine |
| 05/19/2005 | CA2543489A1 Human anti il-15 antibody 146b7 inducing monocytes apoptosis, therapeutical uses thereof |
| 05/19/2005 | CA2543485A1 Use of interferon-tau in medicine |
| 05/19/2005 | CA2543199A1 Use of crth2 antagonist compounds in therapy |
| 05/18/2005 | EP1531158A1 Lipid A and topic, in particular cosmetic, composition thereof |
| 05/18/2005 | EP1530973A2 Methods for inducing T cell tolerance to a tissue or organ graft |
| 05/18/2005 | EP1530725A1 Materials and methods for inductions of immune tolerance |
| 05/18/2005 | EP1530638A2 T-cell epitopes in staphylococcal enterotoxin b |
| 05/18/2005 | EP1530573A1 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 05/18/2005 | EP1530568A1 INDOLE OR BENZIMIDAZOLE DERIVATIVES FOR MODULATING I&kB KINASE |
| 05/18/2005 | EP1530566A1 3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them |
| 05/18/2005 | EP1530565A1 Substituted thiophene carboxamide compounds for the treatment of inflammation |
| 05/18/2005 | EP1530494A1 A pharmaceutical preparation containing palladium complex compounds and the uses thereof for treating cancer and autoimmune disease |
| 05/18/2005 | EP1530484A1 A method of immunomodulation |
| 05/18/2005 | EP1530483A2 T cell receptor cdr3 sequences and methods for detection |
| 05/18/2005 | EP1530473A2 Regulation of erythrocyte apoptosis |
| 05/18/2005 | EP1530466A2 Use of lck inhibitor for treatment of immunologic diseases |
| 05/18/2005 | EP1404656B1 Benzimidazole derivatives for treating microglia-activation associated diseases such as inflammatory, allergic, infectious or autoimmune diseases |
| 05/18/2005 | EP1265860B1 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors |
| 05/18/2005 | EP1263724B1 Novel compounds |
| 05/18/2005 | EP1098885B9 Imidazole compounds and their use as adenosine deaminase inhibitors |
| 05/18/2005 | EP0820461B1 Aryl-ester phosphoramidate derivatives of 2',3'-didehydronucleosides |
| 05/18/2005 | CN1617928A Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers |
| 05/18/2005 | CN1617922A Composition of antibody specifically binding to CD20 |
| 05/18/2005 | CN1617872A Non crystalline tricyclic triazolobenzazepine derivative |
| 05/18/2005 | CN1617865A Phenylalkynes |
| 05/18/2005 | CN1617725A Tyrosyl derivatives and their use as P2X7 receptor modulators |
| 05/18/2005 | CN1617724A Neurotransmitter balance chemotherapy |
| 05/18/2005 | CN1617722A Nicotin-or isonicotin benzothiazole derivatives |
| 05/18/2005 | CN1617704A Composition comprising at least one oxazolin for inhibiting langerhans cell migration, and uses thereof |
| 05/18/2005 | CN1617703A Composition comprising at least one alkanolamide for inhibiting langerhans cells migration, and uses thereof |
| 05/18/2005 | CN1617668A Methods for pretreating a subject with extracorporeal photopheresis and/or apoptotic cells |
| 05/18/2005 | CN1616452A 维生素d类似物 Vitamin d analogues |
| 05/18/2005 | CN1616422A Disulfide derivatives useful for treating allergic diseases |
| 05/18/2005 | CN1616062A Health wine for strengthening immunity and its preparing method |
| 05/18/2005 | CN1616029A Medicine for treating urticaria and skin diseas |
| 05/18/2005 | CN1615961A Concentratend liuweidihuang lozenge and its preparing method |
| 05/18/2005 | CN1615951A Medicine for treating acute urticaria |
| 05/18/2005 | CN1615926A Red sage root biological oral liquor |
| 05/18/2005 | CN1615886A Magnesium iso-glycyrrhetate gel and its preparing method and use |
| 05/18/2005 | CN1615873A Azaindoles compound |
| 05/18/2005 | CN1615842A Preparation for treating allergic rhinitis and asthma |
| 05/18/2005 | CN1615839A Utilization of dialkylfumarates |
| 05/18/2005 | CN1615833A N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 05/18/2005 | CN1615831A Pseudoephedrine hydrochloride dripping pill |
| 05/18/2005 | CN1615828A Garlicin injection emulsion and its preparing method |